Cempra's Solithromycin On Track To Enter Generic, But Resistant, CABP Market
Executive Summary
FDA schedules November advisory committee for Cempra's first-in-class antibiotic for community-acquired bacterial pneumonia.
You may also be interested in...
Recent And Upcoming FDA Advisory Committees
Recent and upcoming FDA advisory committee meetings and a summary of topics covered.
Recent And Upcoming FDA Advisory Committees
Recent and upcoming FDA advisory committee meetings and a summary of topics covered.
Recent And Upcoming FDA Advisory Committees
Recent and upcoming FDA advisory committee meetings and a summary of topics covered.